Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2004 · 15 citations · 12 references
MedicinePediatricsPharmacologyClinical PharmacologyPediatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyOppositional Defiant DisorderPediatric Clinical TrialsPediatric Drug DosingPediatric PharmacologyPsychopharmacology In ChildrenAripiprazole PharmacologyAtypical Antipsychotic TreatmentChild DosingDrug Monitoring In PediatricsOptimal Dosing Regimen DesignPediatric Antipsychotic UsePediatric Psychotropic Dosing
A 9-year-old girl was hospitalized with prolonged somnolence that began 3.5 hours after a single 15-mg dose of aripiprazole. After extensive workup, physical examinations were unremarkable, and all laboratory test results were within normal limits. The patient's extreme somnolence was attributed to aripiprazole, a new atypical antipsychotic prescribed for oppositional defiant disorder. In clinical trials, somnolence has been reported with a frequency of approximately 11%. However, the somnolence experienced by this child was severe, requiring 24-hour hospitalization for observation. Although a recent dose-finding study in 22 pediatric patients (> or = 6 yrs old) described weight-based dosages that were safe and well tolerated, dosing of aripiprazole in children has not been well established. Further studies are needed to identify optimal dosing of aripiprazole in pediatric patients.
12
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Steven G. Potkin, Anutosh Ranjan Saha, Mary J. Kujawa et al. · Archives of General Psychiatry · 2003 · 593 citations